5,7-Dimethoxycoumarin ameliorates vincristine induced neuropathic pain: potential role of 5HT3 receptors and monoamines
Vincristine is the drug of choice for Hodgkin’s lymphoma, acute lymphoblastic leukemia, and non-Hodgkin lymphoma. Despite its significant anticancer effects, it causes dose-dependent neuropathy, leading to compulsive dose reduction. The available drugs used for vincristine-induced neuropathic pain (...
Main Authors: | Muhammad Usman, Hurmat Malik, Ahmed Tokhi, Mehreen Arif, Zilli Huma, Khalid Rauf, Robert D. E. Sewell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1213763/full |
Similar Items
-
7,8-dimethoxycoumarin Attenuates the Expression of IL-6, IL-8, and CCL2/MCP-1 in TNF-α-Treated HaCaT Cells by Potentially Targeting the NF-κB and MAPK Pathways
by: Nari Lee, et al.
Published: (2019-07-01) -
Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
by: Fen Yang, et al.
Published: (2018-08-01) -
Gastrodin attenuates vincristine-induced mechanical hyperalgesia through serotonin 5-HT1A receptors
by: Zheng-Gang Guo, et al.
Published: (2013-12-01) -
Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis
by: Aniek Uittenboogaard, et al.
Published: (2022-01-01) -
Combined Antagonism of 5-HT<sub>2</sub> and NMDA Receptors Reduces the Aggression of Monoamine Oxidase a Knockout Mice
by: Roberto Frau, et al.
Published: (2022-02-01)